Home

Market Capitalization of Godavari Drugs Ltd

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

Market Cap

₹ 65.85 crore

Last updated on: Feb 21, 2025

Key Highlights

  • The Market Cap of Godavari Drugs Ltd is ₹ 65.85 crore as of 21 Feb 25 .
  • The Latest Trading Price of Godavari Drugs Ltd is ₹ 87.45 as of 21 Feb 15:30 .
Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

Share Price

₹ 87.45

2.00 (2.34%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Godavari Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Godavari Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202587.45
20 Feb 202585.45
19 Feb 202587.25
18 Feb 202584.05
17 Feb 202587.35
14 Feb 202590
13 Feb 202593.7
12 Feb 202597.4
11 Feb 2025101.35
10 Feb 2025103.4

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Godavari Drugs Ltd

Asset Value vs Market Value of Godavari Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Godavari Drugs Ltd

No data available

No data available

Historical P/E Ratio of Godavari Drugs Ltd

No data available

* All values are in %

Historical Revenue of Godavari Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Godavari Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Godavari Drugs Ltd

  • Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
  • Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

Godavari Drugs Ltd News Hub

Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter

Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against

Read more

14 Aug 24

Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Power

Read more

10 Aug 24

Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter

Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as aga

Read more

14 Nov 24

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powe

Read more

09 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Godavari Drugs Ltd Market Cap

What is the market cap of Godavari Drugs Ltd?

As of February 22, 2025, Godavari Drugs Ltd has a market capitalization of ₹65.85, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Godavari Drugs Ltd's market capitalization?

Godavari Drugs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Godavari Drugs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Godavari Drugs Ltd's market capitalization change?

Godavari Drugs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions